Cargando…

German evidence and consensus based guidelines 2010 for the treatment of juvenile idiopathic arthritis (JIA)

Detalles Bibliográficos
Autores principales:	Dueckers, G, Guellac, N, Arbogast, M, Dannecker, G, Foeldvari, I, Frosch, M, Ganser, G, Heiligenhaus, A, Horneff, G, Illhardt, A, Kopp, I, Krauspe, R, Markus, B, Michels, H, Schneider, M, Singendonk, W, Sitter, H, Spamer, M, Wagner, N, Niehues, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194537/ http://dx.doi.org/10.1186/1546-0096-9-S1-P181

Ejemplares similares

German evidence- and consensus-based guidelines 2011 for the treatment of juvenile idiopathic arthritis (JIA)
por: Dueckers, Gregor, et al.
Publicado: (2012)

P03-016 - ANTI IL1 refractory CINCA respondes to ANTI IL6
por: Dueckers, G, et al.
Publicado: (2013)

Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany
por: Heiligenhaus, Arnd, et al.
Publicado: (2020)

P03-015 - Dapson treats chronic Pupura Schoenlein (PSH)
por: Dueckers, G, et al.
Publicado: (2013)

Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)
por: Horneff, G, et al.
Publicado: (2008)

Chronic destructive arthritis as an isolated symptom of familial Mediterranean fever (FMF) in a 17 year old Turkish boy
por: Dueckers, G, et al.
Publicado: (2011)

Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry
por: Armaroli, Giulia, et al.
Publicado: (2020)

Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab
por: Horneff, G, et al.
Publicado: (2011)

JIA affected sibling pairs present high correlation for ANA and ILAR category
por: Filocamo, G, et al.
Publicado: (2011)

The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort
por: Sengler, Claudia, et al.
Publicado: (2015)

Methotrexate in oligoarticular persistent juvenile idiopathic arthritis
por: Horneff, Gerd, et al.
Publicado: (2014)

Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry
por: Raab, A., et al.
Publicado: (2021)

Serious infections in JIA patients upon MTX, TFN inhibitors and combinations
por: Horneff, Gerd, et al.
Publicado: (2014)

Outcome of adult patients with JIA treated with the biosimilar Benepali(®): results of the biologic register JuMBO
por: Vollbach, Kristina, et al.
Publicado: (2022)

The German version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Holzinger, Dirk, et al.
Publicado: (2018)

The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON)
por: Listing, Miriam, et al.
Publicado: (2018)

Interleukin (IL)- 6 inhibition - Follow-up data of the German AID-registry(1)
por: Bielak, M, et al.
Publicado: (2015)

MEFV mutations in systemic JIA
por: Aktay Ayaz, N, et al.
Publicado: (2008)

Protocols on classification, monitoring and therapy in children’s rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis
por: Horneff, Gerd, et al.
Publicado: (2017)

Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort
por: Sengler, Claudia, et al.
Publicado: (2018)

Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2019)

PReS-FINAL-2121: Results for 6 minute walk values in healthy German children show similar results as from Britain
por: Foeldvari, I
Publicado: (2013)

Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2020)

PReS-FINAL-2057: Systemic onset JIA with coronary artery dilatation
por: Aktay Ayaz, N, et al.
Publicado: (2013)

P01-048 – Systemic onset JIA with coronary artery dilation
por: Ayaz, N Aktay, et al.
Publicado: (2013)

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry
por: Thiele, Franz, et al.
Publicado: (2021)

Authors reply to the ‘Response to “Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany”’
por: Heiligenhaus, Arnd, et al.
Publicado: (2023)

Mesenchymal stem cells and JIA
por: Swart, JF, et al.
Publicado: (2011)

Epidemiology of JIA
por: Lahdenne, Pekka
Publicado: (2014)

Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
por: Horneff, G, et al.
Publicado: (2015)

IL-6 blockade in systemic juvenile idiopathic arthritis – achievement of inactive disease and remission (data from the German AID-registry)
por: Bielak, M., et al.
Publicado: (2018)

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
por: Officioso, A, et al.
Publicado: (2011)

DNase I levels and disease outcome in JIA patients treated with etanercept
por: Lazarević, D, et al.
Publicado: (2011)

Determing an “autoimmune” phenotype in systemic JIA
por: Fischer, N, et al.
Publicado: (2011)

Accuracy of preliminary remission criteria some JIA category
por: Fantini, F, et al.
Publicado: (2008)

DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
por: Vojinovic, J, et al.
Publicado: (2008)

Prevalence of autoantibodies in patients with juvenile idiopathic arthritis: results from the German inception cohort ICON-JIA
por: Schulz, Caroline, et al.
Publicado: (2022)

JIA pathogenesis - genetics
por: Thomson, Wendy
Publicado: (2014)

Response to Jia and Wang
por: Liu, Xu, et al.
Publicado: (2020)

PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH
por: De Benedetti, F, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_daeobnqjusaflj0548usm1v99o